このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

マッピングストレスと痛みの相互作用(G072323N) (STRAIN)

2026年9月16日 更新者:University Ghent

STRAIN (STRessinpAIN): A Comprehensive Mapping of Stress System Interactions With Pain and Their Contribution to Extent and Chronification of Musculoskeletal Pain

The over-arching goal of this observational (case-control, with a cross-sectional and longitudinal arm) study is to comprehensively map stress system (dys)function (including reactivity and recovery) in people with primary musculoskeletal (MSK) pain and a pain-free control group.

  • The primary objective is to characterize stress systems functioning and their relation to pain in individuals with subacute versus chronic, and localized versus widespread MSK pain, and compare to pain-free controls.
  • The secondary objective is to define the contribution of stress system functioning to trajectories of MSK pain, including pain chronification or recovery from pain.

Researchers will compare primary musculoskeletal pain groups with pain-free controls. Participants will:

  • Fill out online questionnaires.
  • Provide a sample of hair and saliva to assess chronic and acute stress hormone levels, respectively. Saliva samples will be collected both in the lab and at home.
  • Be subject to psychophysiological monitoring.
  • Partake in quantitative sensory testing measuring pain thresholds, tolerances and pain modulation of pressure and heat. These tests will be repeated twice: before and after an acute-stress induction task.
  • Partake in a series of stress-inducting tasks.
  • Be subject to MRI-scans of the brain, including structural and functional MR acquisitions (e.g., during rest and during pain inductions).

Participants will be invited for a second session of the same assessments six months later to observe possible connection between pain trajectory and stress system (dys)function.

調査の概要

状態

招待による登録

研究の種類

観察的

入学 (推定)

140

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Ghent、ベルギー、9000
        • Ghent University, Department of Rehabilitation Sciences

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~55年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Study population is a community sample.

説明

Inclusion Criteria:

• Participants aged 18 to 55 years with a BMI between 17 and 35 kg/m², who are proficient in the Dutch language and do not meet the exclusion criteria listed below

Exclusion Criteria:

  • Body weight >150 kg (maximum weight for the MRI scanner).
  • Postmenopausal individuals.
  • Use of hormone replacement therapy.
  • Current or history of severe psychiatric, neurological (related to the brain, spinal cord, or nerves), endocrine (related to the hormonal system), or cardiovascular (related to the heart and blood vessels) conditions (e.g., cancer, cardiovascular disease, epilepsy, diabetes, etc.).
  • History of spinal surgery, spinal trauma, severe spinal deformities, or neurogenic back pain.
  • Having a severe communicative or cognitive disorder.
  • Use of medication that is not stable for at least 1 month prior to the test session.
  • Regular drug use (≥1 time per week).
  • Contraindications for MRI (such as claustrophobia, implanted electronic devices like a pacemaker, metal splinters in the body, etc.).
  • Currently pregnant or have been pregnant in the past year.
  • Breastfeeding.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:OTHER
  • 時間の展望:CROSS_SECTIONAL

コホートと介入

グループ/コホート
fibromyalgia

Proof of a primary fibromyalgia diagnosis with chronic widespread pain by a specialist-doctor, with an average pain intensity of ≥2/10 on a Visual Analogue Scale, and with pain-related disability indicated by a score of ≥14/70 on the Pain Disability Index.

chronic low back pain

Chronic primary (non-specific) low back pain with primary onset ≥6 months ago, with an average pain intensity of ≥2/10 on a Visual Analogue Scale, and with pain-related disability indicated by a score of ≥14/70 on the Pain Disability Index.

subacute low back pain

Non-specific low back pain with primary onset <3 months ago, with an average pain intensity of ≥2/10 on a Visual Analogue Scale, and with pain-related disability indicated by a score of ≥14/70 on the Pain Disability Index.

pain-free/healthy control

Exclusion criteria include current pain (>0 on a Visual Analogue Scale); a pain condition in the last 6 months for which treatment was sought; history of a chronic pain syndrome.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Quantitative sensory testing - pressure pain threshold
時間枠:At baseline

Determination of mechanical pain sensitivity with a digital pressure algometer, recorded in kg.

At baseline
Quantitative sensory testing - heat pain suprathreshold
時間枠:At baseline

Determination of the mean of heat pain threshold and heat pain tolerance with TSA-2, recorded in °C.

At baseline
Quantitative sensory testing - conditioned pain modulation
時間枠:At baseline

Determination of conditioned pain modulation with a parallel protocol, with test stimulus and conditioning stimulus equal to the heat pain suprathreshold temperature. Pain will be scored on a verbal rating scale 0-100.

At baseline
Quantitative sensory testing - temporal summation of pain
時間枠:At baseline

Determination of temporal summation of pain with a tonic protocol. Heat stimuli will be applied for two minutes, with the temperature equal to the heat pain suprathreshold. Pain will be scored on a verbal rating scale 0-100.

At baseline
Task-based functional MRI - experimental pain induction task
時間枠:At baseline

This type of functional MRI-scanning will allow to capture acute brain responses to (painful) heat stimuli and processes of pain modulation.

At baseline
Salivary cortisol concentration
時間枠:At baseline

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse cortisol concentration; providing information about the hypothalamus-pituitary-adrenal-axis functioning.

At baseline
Salivary alpha-amylase concentration
時間枠:At baseline

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse alpha-amylase concentrations; which gives information about the autonomic nervous system functioning.

At baseline
Salivary oxytocin concentration
時間枠:At baseline

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse oxytocin concentrations; providing information about the oxytocinergic system.

At baseline
Heart rate
時間枠:At baseline

Heart rate, the number of times the heart beat within a certain period, will be measured continuously using ECG (electrocardiogram), providing information on the autonomic nervous system.

At baseline
Heart rate variability
時間枠:At baseline

Heart rate variability (HRV), the fluctuations in time between heart beats, will be measured continuously using ECG. Both time domain and frequency domain of HRV will be examined; providing information on the autonomic nervous system.

At baseline
Skin conductance
時間枠:At baseline

Skin conductance reflects sweat gland activity and will be measured continuously; providing information on the autonomic nervous system.

At baseline
Skin temperature
時間枠:At baseline

Skin temperature, the measurement of the temperature at the skin's surface will be measured continuously; providing information on the autonomic nervous system.

At baseline
Respiration rate
時間枠:At baseline

Respiration rate, the number of breaths taken per minute will be measured continuously; providing information on the autonomic nervous system.

At baseline
Blood pressure
時間枠:At baseline

Blood pressure, the force exerted by circulating blood on the walls of blood vessels, will be measured using non-continuously; providing information on the autonomic nervous system.

At baseline

二次結果の測定

結果測定
メジャーの説明
時間枠
Visual Analogue Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of momentary pain, unpleasantness and stress on a VAS scale ranging from 0-100

At baseline and at the 6-month follow-up
Pain Disability Index - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of pain-related interference in daily activities, recorded on a 0-70 scale

At baseline and at the 6-month follow-up
Pain Catastrophizing Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of catastrophic thinking related to pain, recorded on a scale of 0-52.

At baseline and at the 6-month follow-up
Pain Vigilance and Awareness Questionnaire - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of attention and awareness to pain, recorded on a 0-80 scale.

At baseline and at the 6-month follow-up
General Perceived Recovery - Self-reported
時間枠:At baseline and at the 6-month follow-up

11-point scale to rate perceived recovery from - 5 (vastly worse), through 0 (no change) to + 5 (greatly improved), to assess recovery or persistence of low back pain

At baseline and at the 6-month follow-up
Pain Anxiety Symptoms Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of fear and anxiety associated with pain, recorded on a 0-100 scale.

At baseline and at the 6-month follow-up
Positive and Negative Affect Schedule - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of positive and negative affect levels. Total scores for positive and negative affect range for 10-50 separately.

At baseline and at the 6-month follow-up
Brief Resilience Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of the ability to recover from stress, recorded on a 5-point Likert scale. This questionnaire contains 6 items.

At baseline and at the 6-month follow-up
Intolerance of Uncertainty Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of intolerance to uncertainty, recorded on a scale of 1-5 for each item, with 12 items in total.

At baseline and at the 6-month follow-up
Stress Mindset Measure - Self-reported
時間枠:At baseline and at the 6-month follow-up

Evaluation of beliefs about the nature of stress (enhancing vs. debilitating), recorded on a scale of 0-4 for each item, with 8 items in total.

At baseline and at the 6-month follow-up
Perceived Stress Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of perceived stress over the past month, recorded on a scale of 0-40.

At baseline and at the 6-month follow-up
Hospital Anxiety and Depression Scale - Self-reported
時間枠:At baseline and at the 6-month follow-up

Assessment of anxiety and depression symptoms, recorded on a scale of 0-21 for anxiety and depression subscales separately.

At baseline and at the 6-month follow-up
Childhood Trauma Questionnaire - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of childhood trauma experiences. A shortened version will be used with scores ranging from 0-25. Emotional abuse, physical abuse, and neglect components will be assessed.

At baseline and at the 6-month follow-up
Pittsburgh Sleep Quality Index - Self-reported
時間枠:At baseline and at the 6-month follow-up

Measurement of sleep quality over the past month. A shortened version will be used with scores ranging from 0-12. Component 1-4 will be scored.

At baseline and at the 6-month follow-up
Gender and Pain Questionnaire - Self-reported
時間枠:At baseline and at the 6-month follow-up

Collection of scales of measures for gender conceptualization, gender identity and gendered pain beliefs

At baseline and at the 6-month follow-up
T1 weighted anatomical MRI data
時間枠:At baseline and at the 6-month follow-up

Through Magnetization Prepared-Rapid Gradient Echo, macro-structural properties of grey matter, such as surface area, cortical thickness or volume will be characterized.

At baseline and at the 6-month follow-up
Resting state functional MRI
時間枠:At baseline and at the 6-month follow-up

This type of MRI-scan will allow us to evaluate functional connectivity of the brain.

At baseline and at the 6-month follow-up
Diffusion weighted MRI data
時間枠:At baseline and at the 6-month follow-up

Diffusion weighted MR imaging will provide insights in microstructural properties of white matter (i.e., factional anisotropy, mean diffusivity, etc.).

At baseline and at the 6-month follow-up
Pseudo-Continuous Arterial Spin Labeling - MRI
時間枠:At baseline and at the 6-month follow-up

This type of MRI will provide information on brain blood perfusion parameters.

At baseline and at the 6-month follow-up
Quantitative sensory testing - pressure pain threshold (at follow-up)
時間枠:At the 6-month follow-up

Determination of mechanical pain sensitivity with a digital pressure algometer, recorded in kg.

At the 6-month follow-up
Quantitative sensory testing - heat pain suprathreshold (at follow-up)
時間枠:At the 6-month follow-up

Determination of the mean of heat pain threshold and heat pain tolerance with TSA-2, recorded in °C.

At the 6-month follow-up
Quantitative sensory testing - conditioned pain modulation (at follow-up)
時間枠:At the 6-month follow-up

Determination of conditioned pain modulation with a parallel protocol, with test stimulus and conditioning stimulus equal to the heat pain suprathreshold temperature. Pain will be scored on a verbal rating scale 0-100.

At the 6-month follow-up
Quantitative sensory testing - temporal summation of pain (at follow-up)
時間枠:At the 6-month follow-up

Determination of temporal summation of pain with a tonic protocol. Heat stimuli will be applied for two minutes, with the temperature equal to the heat pain suprathreshold. Pain will be scored on a verbal rating scale 0-100.

At the 6-month follow-up
Task-based functional MRI - experimental pain induction task (at follow-up)
時間枠:At the 6-month follow-up

This type of functional MRI-scanning will allow to capture acute brain responses to (painful) heat stimuli and processes of pain modulation.

At the 6-month follow-up
Salivary cortisol concentration (at follow-up)
時間枠:At the 6-month follow-up

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse cortisol concentrations; providing information about the hypothalamus-pituitary-adrenal-axis functioning.

At the 6-month follow-up
Salivary alpha-amylase concentration (at follow-up)
時間枠:At the 6-month follow-up

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse alpha-amylase concentrations; providing information about the autonomic nervous system functioning.

At the 6-month follow-up
Salivary oxytocin concentration (at follow-up)
時間枠:At the 6-month follow-up

Saliva samples will be taken, with a swab under the tongue for 2 minutes to analyse oxytocin concentrations; providing information on the oxytocinergic system.

At the 6-month follow-up
Heart rate (at follow-up)
時間枠:At the 6-month follow-up

Heart rate, the number of times the heart beat within a certain period, will be measured with ECG continuously, and is part of the autonomic nervous system.

At the 6-month follow-up
Heart rate variability (at follow-up)
時間枠:At the 6-month follow-up

Heart rate variability, the fluctuations in time between heart beats, will be measured with ECG continuously. Both time domains and frequency domains of HRV will be examined. This parameter is part of the autonomic nervous system.

At the 6-month follow-up
Skin conductance (at follow-up)
時間枠:At the 6-month follow-up

Skin conductance reflects sweat gland activity and will be measured continuously; providing information on the autonomic nervous system.

At the 6-month follow-up
Skin temperature (at follow-up)
時間枠:At the 6-month follow-up

Skin temperature, the measurement of the temperature at the skin's surface will be measured continuously; providing information on the autonomic nervous system.

At the 6-month follow-up
Respiration rate (at follow-up)
時間枠:At the 6-month follow-up

Respiration rate, the number of breaths taken per minute will be measured continuously; providing information on the autonomic nervous system.

At the 6-month follow-up
Blood pressure (at follow-up)
時間枠:At the 6-month follow-up

Blood pressure, the force exerted by circulating blood on the walls of blood vessels, will be measured using non-continuously; providing information on the autonomic nervous system.

At the 6-month follow-up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年2月8日

一次修了 (推定)

2026年12月1日

研究の完了 (推定)

2026年12月1日

試験登録日

最初に提出

2025年1月31日

QC基準を満たした最初の提出物

2025年3月17日

最初の投稿 (実際)

2025年3月25日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月21日

QC基準を満たした最後の更新が送信されました

2026年9月16日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

Ghent University will be the data controller. The collected data can only be shared upon request and after finalization of the predetermined statistical analyses and publication of the results. Identifiable data will not be shared. Data sharing is only permitted if all involved parties agree, and if a Data Sharing Agreement is signed.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する